Nonparametric Adjustment for Measurement Error in Time-to-Event Data: Application to Risk Prediction Models

ABSTRACT Mismeasured time-to-event data used as a predictor in risk prediction models will lead to inaccurate predictions. This arises in the context of self-reported family history, a time-to-event predictor often measured with error, used in Mendelian risk prediction models. Using validation data, we propose a method to adjust for this type of error. We estimate the measurement error process using a nonparametric smoothed Kaplan–Meier estimator, and use Monte Carlo integration to implement the adjustment. We apply our method to simulated data in the context of both Mendelian and multivariate survival prediction models. Simulations are evaluated using measures of mean squared error of prediction (MSEP), area under the response operating characteristics curve (ROC-AUC), and the ratio of observed to expected number of events. These results show that our method mitigates the effects of measurement error mainly by improving calibration and total accuracy. We illustrate our method in the context of Mendelian risk prediction models focusing on misreporting of breast cancer, fitting the measurement error model on data from the University of California at Irvine, and applying our method to counselees from the Cancer Genetics Network. We show that our method improves overall calibration, especially in low risk deciles. Supplementary materials for this article are available online.

[1]  D. Hall Measurement Error in Nonlinear Models: A Modern Perspective , 2008 .

[2]  Raymond J. Carroll,et al.  Measurement error in nonlinear models: a modern perspective , 2006 .

[3]  Tianxi Cai,et al.  Landmark Prediction of Long-Term Survival Incorporating Short-Term Event Time Information , 2012, Journal of the American Statistical Association.

[4]  Mitchell H Gail,et al.  Confirmation of family cancer history reported in a population-based survey. , 2011, Journal of the National Cancer Institute.

[5]  N. Graham,et al.  Areas beneath the relative operating characteristics (ROC) and relative operating levels (ROL) curves: Statistical significance and interpretation , 2002 .

[6]  Robert Gray,et al.  Independent review of E2100: a phase III trial of bevacizumab plus paclitaxel versus paclitaxel in women with metastatic breast cancer. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[7]  K. Sweet,et al.  Identification and referral of families at high risk for cancer susceptibility. , 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[8]  D. Berry,et al.  Determining carrier probabilities for breast cancer-susceptibility genes BRCA1 and BRCA2. , 1998, American journal of human genetics.

[9]  Lori E Dodd,et al.  Measurement error in the timing of events: effect on survival analyses in randomized clinical trials , 2010, Clinical trials.

[10]  Christopher I Amos,et al.  Underestimation of risk of a BRCA1 or BRCA2 mutation in women with high-grade serous ovarian cancer by BRCAPRO: a multi-institution study. , 2014, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[11]  Danielle Braun,et al.  Misreported family histories and underestimation of risk. , 2014, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[12]  Jonas Mockus,et al.  The Application Of Bayesian Methods , 1989 .

[13]  N. Obuchowski,et al.  Assessing the Performance of Prediction Models: A Framework for Traditional and Novel Measures , 2010, Epidemiology.

[14]  Malka Gorfine,et al.  Frailty Models for Familial Risk With Application to Breast Cancer , 2013, Journal of the American Statistical Association.

[15]  Argyrios Ziogas,et al.  Validation of family history data in cancer family registries. , 2003, American journal of preventive medicine.

[16]  D. Evans,et al.  False family history of breast cancer in the family cancer clinic. , 1998, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

[17]  E. Murphy,et al.  The Application of Bayesian Methods in Genetic Counselling , 1969 .

[18]  H. Murff,et al.  Does this patient have a family history of cancer? An evidence-based analysis of the accuracy of family cancer history. , 2004, JAMA.

[19]  D. Berry,et al.  Probability of carrying a mutation of breast-ovarian cancer gene BRCA1 based on family history. , 1997, Journal of the National Cancer Institute.

[20]  J. Hughes,et al.  Discrete Proportional Hazards Models for Mismeasured Outcomes , 2003, Biometrics.

[21]  Hormuzd A Katki,et al.  Effect of Misreported Family History on Mendelian Mutation Prediction Models , 2006, Biometrics.

[22]  M. C. Jones,et al.  A reliable data-based bandwidth selection method for kernel density estimation , 1991 .

[23]  Danielle Braun,et al.  Extending Mendelian Risk Prediction Models to Handle Misreported Family History , 2014 .

[24]  H Campbell,et al.  GPs' views on their role in cancer genetics services and current practice. , 1999, Family practice.

[25]  Karl W Broman,et al.  BayesMendel: an R Environment for Mendelian Risk Prediction , 2004, Statistical applications in genetics and molecular biology.

[26]  D. Evans,et al.  The accuracy of diagnoses as reported in families with cancer: a retrospective study , 1999, Journal of medical genetics.